Warangal Doctor Succumbs to Injuries 8 Days After Brutal Attack

Hyderabad: A doctor in Warangal district tragically succumbed to his injuries on Saturday morning, eight days after being allegedly brutally assaulted by his wife’s lover and accomplices.

The gruesome attack took place on February 20 on Battupalli Road. According to officials, the assailants deliberately struck the rear of the doctor’s car, forcing him to stop and step out to inspect the damage. As he stepped out to inspect the damage, they repeatedly struck his head with a hammer before fleeing, believing him to be dead.

Medical Dialogues had earlier reported that in yet another shocking instance of violence against medical professionals, a doctor on his way to Ursu was allegedly brutally assaulted by two unidentified assailants. The assailants reportedly struck him with an iron rod, leaving him with severe injuries.

Also Read: Warangal doctor brutally attacked with iron rod by 2 assailants

According to news reports, passersby rushed the severely injured doctor to MGM Hospital in Warangal before he was transferred to Hyderabad for further treatment. Due to his critical condition, he was brought back to Warangal, where he unfortunately succumbed to his injuries on Saturday morning, officials said.

Following the incident, a complaint was lodged by the doctor’s father. The police swiftly launched an investigation and identified the accused through CCTV footage. On Thursday, police arrested the doctor’s wife, her lover, and their accomplice while they were attempting to sell stolen gold from the victim’s house.

The doctor, a resident of Vasavi Colony, had married in 2016. The couple later moved to Sangareddy in 2018, where his wife worked as a teacher while he served as a contract medical officer at a Primary Health Centre. During this time, the wife allegedly began an extramarital affair with a gym trainer. After the doctor discovered the affair, they returned to Warangal in 2019. However, his wife continued her relationship with the gym trainer and frequently invited him to their home when her husband was away.

Also Read: 4 arrested in case of doctor’s death during Mumbai floods

As per the recent media report by Etv Bharat, it is suspected that to eliminate her husband, Flora and Samuel hatched a murder plot, and she allegedly transferred Rs 1 lakh to Samuel, who then paid Rs 50,000 to Rajkumar, an AR constable in Cyberabad, to carry out the murder. On February 20, the duo entrapped Sumanth while he was returning home from the hospital located in Kazipet, officials said.

Powered by WPeMatico

Non-Registration of FIR of doctor: HC slams Delhi Police, upholds Rs 50,000 fine

The Delhi High Court recently upheld the National Human Rights Commission‘s (NHRC) order directing the Delhi Police Commissioner to pay Rs 50,000 compensation to a senior doctor for not registering an FIR regarding a complaint involving instances of violence against him.

Earlier, the NHRC on 27.09.2023 had recommended that the Commissioner release Rs 50,000 compensation to the doctor. Following this, the order was challenged by the Police Commissioner before the Delhi High Court.

For more information, click on the link below:

Powered by WPeMatico

State Drug Alert: 93 Drug samples including Glenmark’s TELMA AM, Alkem Health Science’s Ondem-4 fail To Qualify CDSCO Test

New Delhi: In line with the ‘Not of Standard Quality’ data provided by states, the apex drug regulatory body, the Central Drug Standard Control Organisation (CDSCO), in its latest drug safety alert, has flagged 93 medicine batches for failing to qualify for a random sample test for January 2025.

The list of drugs declared not of standard quality includes Aceclofenac and Drotaverine Hydrochloride Tablets (100 mg/80 mg) manufactured by Regent Ajanta Biotech, Compound Sodium Lactate Injection I.P (Ringer’s Lactate I.P) manufactured by Paschim Banga Pharmaceuticals, Paracetamol, Cetirizine Hydrochloride & Phenylephrine Hydrochloride Tablets (WINCOLDZ) manufactured by Wings Biotech, BETAHISTINE DIHYDROCHLORIDE tablets IP (Betahox8) manufactured by Jackson Laboratories and others.

In addition, popular medicines such as TELMA AM manufactured by Glenmark Pharmaceuticals and Ondem-4 [Ondansetron Tablets IP] manufactured by Alkem Health Science are on the list of Not of Standard Quality (NSQ) drugs.

The alert stated that, as part of the continuous regulatory surveillance, drug samples are picked from sales/distribution points, analyzed, and lists of Not of Standard Quality (NSQ) drugs are displayed on the CDSCO portal on a monthly basis.

“The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market.” the alert added.

The drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs. Further, the term ‘standards of quality’ is defined under the Section 16 (1) (a) of Drugs and Cosmetics Act, 1940, that the ‘standards of quality’ mean that the drug complies with the standards set out in the Second Schedule of the said Act.

Furthermore, the alert mentioned that NSQ data was received as per format and in an Excel sheet from the state drug licensing authorities of Jammu and Kashmir, Chennai, West Bengal, Puducherry, Telangana, Thiruvananthapuram (Kerala), and Bangalore. Further NSQ data was received from Tripura, Ladakh, and Himachal Pradesh as NIL. However, data was not received as per format in Excel Sheet from Jharkhand (PDF Format), Delhi (PDF Format), Goa (PDF Format), and Maharashtra (PDF Format) for the Month of January 2025 as per DCG (I) Circular dated 09.02.2024.

In addition, the alert noted that State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Haryana, Madhya Pradesh, Manipur, Meghalaya, Nagaland, Odisha, Punjab, Rajasthan, Sikkim, Uttar Pradesh, Uttarakhand, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu; and Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of January, 2025 as per DCG (I) Circular dated 09.02.2024.

Also Read:84 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert

NOT OF STANDARD QUALITY ALERT FOR THE MONTH OF JANUARY– 2025

B. State Laboratories

S.No

Product/Dr ug Name

Batch No.

Manufa cturing Date

Expiry Date

Manufactured By

NSQ Result

Reported by State Laboratory

1.

PC-WIN- 650

VGT2316 99C

09/23

08/25

Mfg By: Vrindavan Global Plot No. 23-B & C , Ind. Area Lodhimajra Baddi Distt. Solan (HP) 173205

Mrk. By: In Med Therepeutics Plot No. 286, Basement Part-I,

Industrial Area , Phase I , Panchkula -134113

The sample does not conform to IP 2022 with respect to the test for Dissolution

Drug Testing Laboratory Srinagar (J&K) – Report attached as Annexure A

2.

Aceclofenac & Drotaverine Hydrochlori de Tablets (100 mg/

80 mg)

PRT2401

-01

01/2024

45992

M/s. Regent Ajanta Biotech, 86-87, Village Makhiyali Dundi, Peerpura Road, Roorkee- 247667 (U.K)

Description

Karnataka

3.

Compound Sodium Lactate Injection I.P (Ringer’s Lactate I.P)

03BF231

9

Dec/202 3

46327

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Bacterial Endotoxins Test

Karnataka

4.

Compound Sodium

Lactate

03BF224

1

45200

09/2026

M/s. Paschim Banga Pharmaceuticals, (A Unit of

Farista Vanijya Pvt. Ltd), NH-

Test for Sterility

Karnataka

Injection I.P (Ringer’s

Lactate I.P)

31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

5.

Compound Sodium Lactate Injection I.P (Ringer’s Lactate I.P)

03BF226

0

Oct/202 3

46266

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Test for Sterility

Karnataka

6.

Compound Sodium Lactate Injection I.P (Ringer’s

Lactate I.P)

03BF231

8

45261

46327

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Bacterial Endotoxins Test” and “Test for Sterility

Karnataka

7.

Compound Sodium Lactate Injection I.P (Ringer’s

Lactate I.P)

03BF225

6

45200

46266

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Test for Sterility

Karnataka

8.

Compound Sodium Lactate Injection I.P

(Ringer’s Lactate I.P)

03BF238

9

45323

46388

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Test for Sterility

Karnataka

9.

Compound Sodium Lactate Injection I.P (Ringer’s

Lactate I.P)

03BP005

7

Sep/202 3

46235

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Test for Sterility

Karnataka

10.

Compound Sodium Lactate Injection I.P

03BF232

8

45261

46327

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

Bacterial Endotoxin Test” and “Test for Sterility

Karnataka

(Ringer’s

Lactate I.P)

HAT, PS. Chopra Dist. Uttar

Dinajpur-733214 (W.B)

11.

Compound Sodium Lactate Injection I.P

(Ringer’s Lactate I.P)

03BP006

0

09/2023

46235

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Test for Sterility

Karnataka

12.

Compound Sodium Lactate Injection I.P (Ringer’s

Lactate I.P)

03BF232

9

45261

46327

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Bacterial Endotoxin Test” and “Test for Sterility

Karnataka

13.

Compound Sodium Lactate Injection I.P (Ringer’s Lactate I.P)

03BF221

0

Sep/202 3

46235

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Test for Sterility

Karnataka

14.

Compound Sodium Lactate Injection I.P (Ringer’s Lactate I.P)

03BP012

0

Jan/202 4

46357

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Test for Sterility

Karnataka

15.

Compound Sodium Lactate Injection I.P (Ringer’s

Lactate I.P)

03BF234

2

45261

46327

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Sterility Test”

Karnataka

16.

Compound Sodium Lactate Injection I.P (Ringer’s

Lactate I.P)

03BF225

4

45200

46266

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Sterility Test

Karnataka

17.

Compound Sodium Lactate Injection I.P (Ringer’s

Lactate I.P)

03BF236

9

Dec/202 3

46327

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Bacterial Endotoxin Test

Karnataka

18.

Compound Sodium Lactate Injection I.P (Ringer’s Lactate I.P)

03BP011

5

45261

46327

M/s. Paschim Banga Pharmaceuticals, (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, TIN MILE HAT, Sonapur

HAT, PS. Chopra Dist. Uttar Dinajpur-733214 (W.B)

Test for Sterility and Bacterial Endotoxins Test

Karnataka

19.

Aceclofenac

,

Paracetamo l and Chlorzoxazo ne Tablets (Megaceclo MR)

AMT2407 160

45474

46174

M/s. Marine Medicare Pvt. Ltd., Vill. Kulhariwala & P.O. Mandhala, Tehsil-baddi, Distt.

Solan (H.P) 174 103

On the received sample presence of spots observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of

Spot/discoloration- NSQ

puducherry

20.

Paracetamo l, Cetirizine Hydrochlori de & Phenylephri ne Hydrochlori de Tablets (WINCOLD Z)

WNZT- 3240

45231

46296

M/s Wings Biotech LLP., 43 & 44, HPSIDC, Industrial Area, Baddi-173 205 (H.P)

On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets

vide serial No.(i) Presence of

puducherry

Spot/discoloration –

NSQ

21.

Cefpodoxim e Proxetil Tablets IP 200 MG (RIZDOX- 200)

VCT/129

45139

45839

M/s Vats Biotech Pvt Ltd,(An ISO 9001:2015 GMP,GLP

Certified co) Vill.Kailar, P.O. Saproon, Teh & Distt Solan- 173 211 (H.P)

On the received sample Discoloration,rough surface and picking defects were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration (iv)Picking and

(vii)Rough surface. – NSQ

puducherry

22.

Calcium Carbonate & Vitamin D3 Tablets (VICTOCAL – D3)

MDP – 746

45536

46235

M/s. MEDINOK HEALTHCARE PVT LTD., R.S.No. 2/1, Plot

No. 87,88,89, Vazhudhavur Main Road, Kurumbapet, Puducherry – 605 009.

The sample received is labelled as CALCIUM CARBONATE & VITAMIN D3

TABLETS, however CALCIUM CARBONATE & VITAMIN D3

TABLETS is an official IP monograph (2022) hence should be labelled as CALCIUM AND VITAMIN D3 TABLETS IP. – Label

issue

puducherry

23.

Pregabalin (SR) &

MP – 240724

45566

46266

M/s. Medistark Biotech Pvt.

Ltd., R.S.

The label of the container in the drug is

puducherry

Methylcobal amin Tablet (Mecoben – PG)

No. 68/4, 68/10, Sri

Srinivasapuram, Agasampattu, Vanur Tk, Tamilnadu – 605 111.

mentioned as ‘Approved colour used’ but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. –

Misbranded

24.

Thiamine Hydrochlori de Tablets IP 100mg (KTHAMINE

-100)

ZRST- 1361

45505

46023

M/s. ZRS PHARMACEUTICALS INDIA

PVT LTD., Khasra No 48, 490/3,562/489/1, Opposite Sector-6, Tehsil Kasauli, Parwanoo, Solan, HP-173220

(i) On the received sample, Presence of

Spot defect was observed which should not be present as per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration. (ii)The label of the container in the drug is mentioned as ‘Approved colour used’ but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned.

(iii) The label claim of the drug states

‘Thiamin hydrochloride IP 100mg’ instead of ‘

puducherry

Thiamine Hydrochoride IP 100mg’ but the proper name of the drug should be written as prescribed under 96(1),(i)(A) of The

Drugs and Cosmetics Act.

(iv) The label claim of the received sample

states Thiamin Hydrochloride IP 100mg whereas in the IP monograph, The usual strength of the thiamine tablet is stated as 5mg, 10mg, 50mg. Hence,the Strength of the sample received does not match the usual strength as mentioned in the IP monograph.

– NSQ

25.

Paracetamo l, Phenylephri ne HCl, Caffeine & Diphenhydr amine HCl Tablets (CINKOLD)

SG034B0 3

44958

45658

M/s. Sharun Pharmaceuticals Pvt Ltd.,R.S. NO: 195/9 &

197/4, Pangoor, Ariyur Revenue Village, Villianur, Puducherry-605102

NOTE:(i) On the received sample, Presence of Spot defect was observed which should not be present as per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets

vide serial No.(i) Presence of

puducherry

Spot/discoloration. (ii)The label of the container in the drug is mentioned as ‘Approved colour used’ but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not

mentioned. vel – NSQ

26.

BETAHISTI NE DIHYDROC HLORIDE TABLETS

IP (Betahox- 8)

T-18946

44958

45658

M/s Jackson Laboratories Pvt Ltd., Plot No . 56 & 61, Industrial Area, Phase- III, Sansarpur Terrace, Distt.

Kangra (H.P)-176501

On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of

Spot/discolouration. – NSQ

puducherry

27.

Aceclofenac and Thiocolchico side Tablets (Speronac – MR)

P240502

45413

46113

M/s.– Prosilio Pharmaceuticals Pvt. Ltd., R.S.No. 35/6,

Uruvaiyar Main Road, Uruvaiyar, Villianur Commune, Puducherry – 605 110.

On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets

vide serial No.(i) Presence of

puducherry

Spot/discoloration. –

NSQ

28.

Clopidogrel Tablet I.P 75 mg (Maxgrel – 75)

MDP – 309

45444

46143

M/s. Medinok Healthcare Pvt. Ltd., (A GMP & ISO 9001:2015

Certified Company) R.S.No. 2/1, Plot No. 87,88,89,

Vazhudhavur Main Road, Kurumbapet, Puducherry – 605 009

(i) On the received sample, Presence of Spot and discoloration defects were observed

which should not be present as per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration. (ii)The label of the container in the drug is mentioned as ‘Approved colour used’ but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned.

(iii) On the received sample, The name of the manufacturer and

the address of the premises of the manufacturer appears in an inconspicuous manner on the label whereas they should appear in a conspicuous manner

puducherry

as prescribed under 96 (1) (iv) of the Drugs and Cosmetics Act.

(iv) On the received sample,the label

details of the primary packing does not match with that of the secondary packing (Excipients …q.s is not mentioned in primary packing)- NSQ

29.

Mecobalami n Sublingual Tablets 1500 mcg (Re- Xite BTX)

D240601 9

45444

46143

M/s LINUX LIFE SCIENCES PVT LTD., R.S. No.241/1 &

241/5, Kalitheerthalkuppam, Madagadipet Post, Mannadipet commune,Puducherry- 605

107, India.

On the received sample, Presence of Spot defect was observed which should not be present as per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of

Spot/discoloration.- NSQ

puducherry

30.

Amoxycillin Trihydrate Capsules (RIMOXIN)

RIX-040

45292

45992

M/s RIPPON LABORATORIES

No.44,45, Pazaniyappa Nagar, Othiyampet, Villianur, Puducherry-605 110

The sample received is labelled as AMOXYCILLIN TRIHYDRATE

CAPSULES , however AMOXYCILLIN TRIHYDRATE

CAPSULES is an official IP monograph (2022) hence should be labelled as

AMOXYCILLIN

puducherry

TRIHYDRATE CAPSULES IP.- Label

issue

31.

Metoprolol Succinate Extended Release & Telmisartan Tablets (Leaftel Beta – 25)

MP – 231584

45352

46054

M/s. Medistark Biotech Pvt. Ltd., R.S.No. 68/4, 68/10, Sri

Srinivasapuram, Agasampattu, Vanur (TK), Tamilnadu – 605 111

The label of the container in the drug is mentioned as ‘Approved colour used’ but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. –

Misbranded

puducherry

32.

Lucos-LM kid suspension

AMS2341 6

12/2023

11/2025

Alop Med-Sciences Pvt Ltd, Shamti, Solan-173212.H.P

Sample does not conform to Label claim with respect to the content of Levocetirizine Hydrochloride and

Montelukast in Montelukast Sodium.

Drugs Testing Laboratory, Chennai – 6

33.

Spironolacto ne Tablets IP

T- 2403993

03/2024

02/2026

Oscar Remedies Pvt. Ltd, Oscar House, Badi Majra, Yamuna Nagar(HR) – 135001

Sample does not conform to IP specification for Spironolactone Tablets with respect to

Dissolution

Drugs Testing Laboratory, Chennai – 6

34.

Nozal Cream

3447

03/2024

02/2026

Olcare Laboratories, 505/A, G.I,D.C, Estate, Wadhwancity- 363035. Dist. Surendranagar- (GUJ)

Sample does not conform to BP Specification for Ketoconazole Cream with respect to the content of Ketoconazole.

Drugs Testing Laboratory, Chennai – 6

35.

Gentamicin Injection IP- 2ml

24BUE74

05/2024

04/2026

SVP Life Sciences, C/10-1, Sara Industrial Estate, Selequi, Dehradun

Sample does not conform to the requirement for PH.

King Institute of Preventive Medicine & Research, Guindy,

Chennai-32

36.

Sucralfate and Oxetacain Suspension

SEL2401

01/2024

12/2025

CU-V-Kar Genetic Medicines Pvt Ltd, 14, Pharmacity, Selaqui, Distt. Dehradun, Uttarakhand-248011.

Sample does not conform to Label claim with respect to content of Oxetacaine.

Drugs Testing Laboratory, Madurai -19.

37.

Aspirin Tablets

TAS2301 0AL

10/2023

09/2025

Hindustan Laboratories Limited, Plot No, 5-9, Survey NO.38/2, Aliyali, Palghar (W), Dist. Palghar 4041404(MS)

Sample does not conform to IP Specification for Aspirin Tablets with respect to the content

of Aspirin.

Drugs Testing Laboratory, Madurai -19.

38.

Nozal

4246

10/2024

09/2026

Olcare Laboratories, 505/A, G.I,D.C, Estate, Wadhwancity- 363035. Dist. Surendranagar- (GUJ)

Sample does not conform to BP Specification for Ketoconazole cream with respect to the content of

Ketoconazole

Drugs Testing Laboratory, chennai – 6

39.

Amoxycillin Dispersible Tablets IP 125 mg

PGA24- 001

01/2024

12/2025

Pondchy Pharmaceuticals, R.S.No.218/4, 218/5,

Odiaampet, Manaveli Road, Villianur Commune, Puducherry, 605110.

Sample does not conform to IP Specification for Dispersible Tablets with respect to uniformity of

Dispersion and Disintegration

Drugs Testing Laboratory, chennai – 6

40.

Povinanz Gargle

ES40030

03/2024

02/2026

Nanz med Science Pharma Pvt Ltd, Rampur Ghat, Paonta Sahib, District Sirmour (H.P) India – 173 025

sample does not conform to label with respect to the content of available iodine in povidone-iodine

Drugs Testing Laboratory, chennai – 6

41.

Amoxycillin Dispersible Tablets IP

125 mg

PGA24- 006

08/2024

07/2026

Pondchy Pharmaceuticals, R.S.No.218/4, 218/5,

Odiaampet, Manaveli Road,

Sample does not conform to IP Specification for

Dispersible Tablets

Drugs Testing Laboratory, chennai – 6

Villianur Commune, Puducherry, 605110.

with respect to uniformity of Dispersion and

Disintegration

42.

Ttocin Ointment, Mupirocin with Tea Tree Oil Ointment

MVO-070

10/2024

09/2026

Bonn Schetering Bio Sciences, Plot No.64 & 65, 1st Floor, Electronic park, Thirubuvanai, Mannadipet Commune, Puducherry, 605107.

Sample does not conform to label claim with respect to the content of mupirocin.

Drugs Testing Laboratory, chennai – 6

43.

Flumethrin 1% Porur- On Solution

EE- 240906

09/2024

08/2026

Ethicare Laboratories, 15, Industrial Estate, Digiana, Jammu-180010

Sample does not conform to Lablel Claim with respect to

the content of Flumethrin.

Drugs Testing Laboratory, Madurai -19.

44.

Sucnol-O Suspension

SCI-2305

11/2023

10/2025

Apple Formulations Pvt Ltd, Plot No.208, Kidhsnpur, Roorkee-247667(U.K)

Sample does not conform to Label Claim with respect to the content of

Oxetacaine

Drugs Testing Laboratory, Madurai -19.

45.

Betamethas one Valerate Ointment IP 0.1% w/w

B76

08/2024

07/2026

Syndicate Pharma, 185/B, 185/B-1, 187/A & 188, sector – F, Sanwer Road, Indore- 452015.

Sample does not conform to IP Specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.

Drugs Testing Laboratory, chennai – 6

46.

Co- Trimoxazole Tablets IP 480mg

MT402

01/2024

12/2026

Maxwell Lifescience Pvt Ltd, T- 53 & T-81, M.I.D.C, Tarapur,

Boisar, Dist, Palghar, 401506.

Sample does not conform to IP Specification for Co- Trimoxazole Tablets with respect to Dissolution for Trimethoprim and Sulphamethoxazole

Drugs Testing Laboratory, chennai – 6

47.

N-Clin Gel

M030

07/2024

06/2026

Elegant Cosmed Pvt Ltd, Plot No.32&33, G.I.D.C, Rajkot,

Gujarat, Kuvadva – 360023

Sample does not conform to label claim with respect to the content Clindamycin in Clindamycin

Phosphate

Drugs Testing Laboratory, chennai – 6

48.

Gentamicin Injection IP- 2ml

24BUF83

06/2024

05/2026

SVP Life science, C/10-1, Sara industrial Estate, Selequri, Dehradun

sample does not Conform to the requirement for PH

King Institute of Preventive Medicine & Research, Guindy, Chennai-32

49.

Gentamicin Injection IP- 2ml

HLI620F

06/2024

05/2026

Himalaya Meditek Private Ltd, Plot.No 35&36 Pharmacity, Selaquri Industrial Ara,

Dehradun – 248 197

sample does not Conform to the requirement for PH

King Institute of Preventive Medicine & Research, Guindy,

Chennai-32

50.

Gentamicin Injection IP- 2ml

HLI615F

06/2024

05/2026

Himalaya Meditek Private Ltd, Plot.No 35&36 Pharmacity, Selaquri Industrial Ara, Dehradun – 248 197

sample does not Conform to the requirement for PH

King Institute of Preventive Medicine & Research, Guindy, Chennai-32

51.

Gentamicin Injection IP- 2ml

HLI623F

06/2024

05/2026

Himalaya Meditek Private Ltd, Plot.No 35&36 Pharmacity, Selaquri Industrial Ara,

Dehradun – 248 197

sample does not Conform to the requirement for PH

King Institute of Preventive Medicine & Research, Guindy,

Chennai-32

52.

Gentamicin Injection IP- 2ml

23BUH50

08/2023

07/2025

SVP Life science, C/10-1, Sara industrial Estate, Selequri, Dehradun

sample does not Conform to the requirement for PH

King Institute of Preventive Medicine &

Research, Guindy, Chennai-32

53.

Gentamicin Injection IP- 2ml

HLI628F

06/2024

05/2026

Himalaya Meditek Private Ltd, Plot.No 35&36 Pharmacity, Selaquri Industrial Ara,

Dehradun – 248 197

sample does not Conform to the requirement for PH

King Institute of Preventive Medicine & Research, Guindy,

Chennai-32

54.

Ketoya Soap

MO26

08/2024

07/2026

Elegant Cosmed Pvt Ltd, Plot No.32&33, G.I.D.C, Rajkot,

Kuvadva – 360023,Gujarat,

sample does not conform to label claim with respect to the content of Ketoconazole

Drugs Testing Laboratory, chennai – 6

55.

Betamethas one

Valerate

BO6

05/2024

04/2026

Syndicate Pharma, 185/B, 185/B-1, 187/A & 188, sector –

Sample does not conform to IP

specification for

Drugs Testing Laboratory,

chennai – 6

Oilment IP 0.1% w/w

F, Sanwer Road, Indore- 452015.

Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone

Valerate.

56.

Mupirocin Ointment IP

SO-033

03/2024

02/2026

SB Lifesciences pvt ltd, At.Plot No.45, EPIP, Phase-I,

Jharmajri Baddi, Dist Solan (HP)-173205

Sample does not conform to IP specification for Mupirocin Ointment with respect to the content of Mupirocin

Drugs Testing Laboratory, Madurai -19.

57.

Mupirocin Ointment IP

ME-41

02/2024

01/2026

Maxwell pharma, Plot No.6&7, Sector-5, Parwanoo, Solan,

H.P PIN-173220, India

Sample does not conform to IP specification for Mupirocin Ointment with respect to identification and

content of mupirocin

Drugs Testing Laboratory, Madurai -19.

58.

Lukus

G198

06/2024

05/2026

INDKUS Biotech India, Vill manuja rampur jattan, Moginand, Kala amb, Sist.sirmour (HP) – 173001

Sample does not conform to IP specification for Luliconazole Cream with respect to the

content of Luliconazole

Drugs Testing Laboratory, Madurai -19.

59.

Coscopin Cold Plus

CSP2300 1

06/2023

05/2025

Windlas Biotech Limited (Plant- 2) Khasra No.141 to 143 & 145, Mohabewala, Indl. Area, Dehradun-248110.

Uttarakhand.

Sample does not conform to Label claim with respect to the content of Phenylephrine

Hydrochloride

Drugs Testing Laboratory, Madurai -19.

60.

Mobicool TM-S

Suspenion

RL- 231203

02/2024

01/2026

Rednex pharmaceuticals,LS No-142, NR, HBS,

Chancharvadi Vasna, Ta: sanand Di: Ahmedabad

Sample does not conform to Label claim with respect to content Oxetacaine

Drugs Testing Laboratory, Madurai -19.

61.

Mupirocin Ointment IP 2% w/w

NO33015 6

11/2023

10/2025

Nanz med Science Pharma Pvt Ltd, Rampur Ghat, Paonta Sahib, District Sirmour (H.P) India – 173 025

Sample does not conform to IP specification for Mupirocin Ointment with respect to the

content of mupirocin

Drugs Testing Laboratory, Madurai -19.

62.

Luliconazole Cream IP 1% w/w

2946

05/2024

04/2026

Regent Ajanta Biotech, 86-87, Village Makhiyali Dundi, Peerpura Road, Roorkee – 247667 (UK)

sample does not Conform to IP Specification for Luliconazole Cream with respect to the PH of 10% w/v solution.

Drugs Testing Laboratory, Madurai -19.

63.

Cefixime & Lactic Acid Bacillus Dispersible Tablets

MLS- 24506

07/2024

06/2026

Maskon Life sciences pvt ltd, Kh.No.69/70, Khatakheri, Bhagwanpur, Roorkee 247667 (UK) India

Sample does not conform to label claim with respect to the content of Anhydrous

Cefixime in Cefixime Trihydrate

Drugs Testing Laboratory, Madurai -19.

64.

VIP Hair Colour Shampoo

B107C

06/2024

05/2026

VIMAC, #18/C. Noombal Village, SF.No.125/1A, 1B, Ambattur, Taluk, Tiruvallur District, Chennai-600077.

Sample does not conform to BIS specification for oxidation hair dye with respect to the content of phenyl methyl

pyrazolone and Resorcinol

Drugs Testing Laboratory, Chennai – 6

65.

B&B Beaute Blanc Hair Colour Conditioner Natural Black

2201202

4

22.01.2

024

21.01.2

027

Gabt Co Ltd, Guanzhou, China.

The sample is found to contain m- phenylenediamine which must not form part of the conposition of cosmetics products as per BIS specification 4707

(Part 2): 2017, under Annex A (clauses 1,2 and 3.1), serial No.1198.

Drugs Testing Laboratory, Chennai – 6

66.

Nyomi Fruit Vinegar Black Hair Gel Colour

2024071

2

12.07.2

024

11.07.2

027

Guangzhou Aocai Bio- Technology Co. Ltd, Address.

Building D.No.10, Shi Longgang Industry, Chang Yaoling Village, Zhong Luotan Town, Guangzhou, China.

Sample does not conform to BIS Specification for Oxidation Hair dye with respect to the content of Phenyl

Methyl Pyrazole.

Drugs Testing Laboratory, Chennai – 6

67.

Xputum-LS Syrup

24-XLS-

010

02/2024

07/2025

Stedman Pharmaceuticals Pvt Ltd, C-4, SIDCO

Pharmaceuticals Complex, Alathur, Thiruporur-603 110, Tamilnadu.

Sample does not conform to Label Claim With respect to content of Levosalbutamol in Levosalbutamol

Sulphate.

Drugs Testing Laboratory, Madurai -19.

68.

Podine-M

PM 04

04/2024

03/2026

Karlin Pharmaceuticals & Exports Private Limited, No.2/140, Indira Nagar, Valasaravakkam, Chennai – 600087

sample does not conform to label claim with respect to the content of available iodine in povidone iodine

Drugs Testing Laboratory, Chennai – 6

69.

Mupirocin Ointment IP

DC2437

03/2024

08/2025

Arius Formulation Private Limited, R.S.No.141/1, Groud floor, Navarkulam Main Road, Pattanur, Tamilnadu – 605101

Sample does not conform to IP Specification for Mupirocin Ointment

with respect to the content of Mupirocin

Drugs Testing Laboratory, Madurai-19

70.

Cumox 500

FDCX- 076

10/2024

09/2026

Firstmed Therapeuticals pvt ltd, R.S.No.31/1, Pondy- Tindivanam Main Road, Auroville (PO), Thiruchitrambalam, Tamilnadu

– 605 101

Sample does not conform to IP specification for Amoxycillin capsules with respect to Uniformity of Weight and to the content of

Amoxycillin in Amoxycillin Trihydrate.

Drugs Testing Laboratory, Chennai – 6

71.

Norfloxacin Tablets IP 400mg

RNFT- 017

10/2024

.

09/2026

.

Mfg By: Revat Laboratories Pvt.Ltd., 12-321, Opp. I.D.A,

Kurnool Road, Pernamitta,

NOT OF STANDARD QUALITY

Dissolution test does

State Lab, Drugs Control

Ongole – 523 002 Andhra Pradesh.

not complies for Norfloxacin Tablets IP at S2 Level as per IP

2022.

Laboratory, Telangana.

72.

Cefpodoxim e & Potassium Clavulanate Tablets

BPT- 3003

02/2024

.

01/2026

.

Mfg By: Geenac Pharma Plot No: 582, Raipur, Bhagwanpur, Roorkee, Uttarakhand-247667.

Uttarakhand.

.

Mrkt: Wellnow Healthcare Kanal Industrial Estate, Road No. 6, Borivali East, Mumbai – 400 066.

NOT OF STANDARD QUALITY

The sample does not meets the Specifications wrt.

Identification test – and Assay – for Cefpodoxime and Clavulanic Acid as per STP. U/S. 17 B of

Drugs and Cosmetics Act 1940. The Sample is deemed to be Spurious Drug.

State Lab, Drugs Control Laboratory, Telangana.

73.

Norfloxacin Tablets IP 400mg

RNFT- 014

12/2023

.

11/2025

.

Mfg By: Revat Laboratories Pvt.Ltd., 12-321, Opp. I.D.A,

Kurnool Road, Pernamitta, Ongole – 523 002 Andhra Pradesh.

NOT OF STANDARD QUALITY

Dissolution test does not complies for Norfloxacin Tablets IP at S2 level as per IP 2022.

State Lab, Drugs Control Laboratory, Telangana.

74.

Parenteral preparations

, Piperacillin & Tazobactam Injection I.P.

4.5 gm

24PT41

11/2024

.

10/2026

.

Mfg By: Sai parenterals limited D1&D4, Survey no. 280, Phase

– V Survey No. 280, Phase – V, IDA, Jeedimetla, Hyderabad – 500055, Telangana, India Telangana.

NOT OF STANDARD QUALITY

Test for sterility does not complies as per IP for the sample Piperacillin and

Tazobactam injection IP 4.5 gm

State Lab, Drugs Control Laboratory, Telangana.

75.

Retibak (0.2%

Retinol) Face Serum

AHO2400 48

23-07-

2024.

06/2026

.

Mfg By: M/s. Aarohee healthcare Private Ltd, Sy.No. 751 & 757 Burgula (V), Farooq Nagar (M), Rangareddy District.

NOT OF STANDARD QUALITY

Sample does not meets the specifications wrt. to

State Lab, Drugs Control Laboratory, Telangana.

Manufactured for : M/s. Origo cosmeceuticals Pvt.Ltd.,

.

Marketed By: Cosmonova Medicare Pvt. Ltd., No.

18/5(A), 1st main S.R. Nagar, Richmond Road, Bangalore – 560 027.

identification test for Retinol as per STP.

76.

Pantoprazol e tablets IP

P03524

09/2024

.

08/2026

.

Mfg By: Spansules formulations India Pvt.Ltd, Sy NO.172, Plot No. 154/A4, IDA

bollaram village Jinnaram mandal, Sangareddy dist,

Hyderabad – 502 325, Telangana.

NOT OF STANDARD QUALITY

Assay and Dissolution test does not complies for Pantoprazole tablets as per IP

2022.

State Lab, Drugs Control Laboratory, Telangana.

77.

Kaltfer Drops Iron(III)- Hydroxide Polymaltose Complex Drops.

EHL- 3532

07/2024

.

12/2025

.

Mfg By: M/s. Exotic Healthcare Plot No. 1305, Sector – 82, JLPL, Mohali, SAS Nagar, Punjab.

.

Mrkt: M/s. Curezen Pharma Pvt. Ltd, Pharmaceuticals No. 2/A/GF/FF/SF, Ground floor, Vijaynagar colony, Secunderabad, Hyd – 500025.

NOT OF STANDARD QUALITY

The sample Does not meets the Specifications wrt.

Identification Test – Negative, Assay – Nil as per STP. U/S. 17 B of Drugs and Cosmetics Act 1940.

The Sample deemed to be Spurious Drug.

State Lab, Drugs Control Laboratory, Telangana.

78.

Ondansetro n orally disintegratin g tablets IP 4 mg

T-15842

12/2023

.

11/2025

.

Mfg By: Karnani Pharmaceuticals Pvt.Ltd, fact:38 Pharma city, Selaqui Dehradun – 248 011.

Uttarakhand.

NOT OF STANDARD QUALITY

While opening the strip, it is found that the tablets are not in intact condition.

Received 50 tablets,

out of 50 tablets, 40 tablets are not in intact condition. Hence sample is of Not of

State Lab, Drugs Control Laboratory, Telangana.

Standard Quality with respect to Description

test parameter.

79.

TELMA AM

5240367

45352

46419

M/s. Glenmark Pharmaceuticals Ltd., Solan H.P.

Does not confirm to I.P.

State Drugs Testing Laboratory, Kolkata, West Bengal.

80.

CLAVPARK

-LB 625mg

(Amoxycillin

, Potassium Clavulanate & Lactic Acid Bacillus

Tab)

CHTJ426 0

45566

46266

M/s. Park Pharmaceuticals, Vill. Kalujhanda, Solan, H.P

Does not confirm to claim

State Drugs Testing Laboratory, Kolkata, West Bengal.

81.

Cetirizine Syrup IP

CE3010

09/23

08/25

Kerala State Drugs and Pharmaceuticals Limited, Kalavoor .P.O, Alappuzha -688 522

It fails the test ‘Assay’ as per IP

Drugs Testing Laboratory Thiruvananthapuram

82.

Paradolo 500

[Paracetam ol Tab IP 500 mg]

AGT4055 4

05/24

04/27

Alventa Pharma Ltd, Vill, Kishanpura, Baddi-Nalagarh Road, Tehsil, Baddi, Distt.

Solan (HP) 174 101

It fails the test ‘Dissolution’ as per IP

Drugs Testing Laboratory Thiruvananthapuram

83.

Cetirizine Syrup IP

CE 3008

09/23

08/25

Kerala State Drugs and Pharmaceuticals Limited, Kalavoor .P.O, Alappuzha -688 522

It fails the test Assay and content of packaged dosage forms specified in the laboratory protocol as

per IP

Drugs Testing Laboratory Thiruvananthapuram

84.

Ondem-4 [Ondansetro n Tablets

IP]

2444145

1

04/24

03/26

Alkem Health Science, Unit -2, Samardung, Karek Block, P.O Namthang District Namchi,

Sikkim – 737 137

It fails the test dissolution specified in the Laboratory

Protocol as per IP

Drugs Testing Laboratory Thiruvananthapuram

85.

Liquid Paraffin IP 400 ml

HP 24002

07/24

06/26

Multicure Pharma Private Limited,Factory 14 A, IAD, Yadadri Bhongir- 508 116,

Hyderabad

It fails the tests ‘Weight per ml and ‘Light Absortion’ as per

IP

Drugs Testing Laboratory Thiruvananthapuram

86.

Cetirizine Syrup IP

CE4019

05/24

04/26

Kerala State Drugs and Pharmaceuticals Limited, Kalavoor .P.O, Alappuzha -688 522

It fails the tests Microbial contamination in non- sterile products as per

IP

Drugs Testing Laboratory Thiruvananthapuram

87.

Tuclav -CV 625[

Amoxycillin and Potassium Clavulanate Tab IP

MYRTAB

-618

08/24

01/26

Mayer Lab, Chambaghat, Adjacent to Railway Crossing, District Solan (HP)- 173 213

It fails the test Dissolution and Assay as per IP

Drugs Testing Laboratory Thiruvananthapuram

88.

Losartan Potassium Tab IP 25

mg

D 2615/24-

25

Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14

It fails the ‘Descriptive Part’ for the tablets as per IP , tablets should have sufficient hardness for handling without crumbling and

breaking

Drugs Testing Laboratory Thiruvananthapuram

89.

Fexofenadin e Hydrochlori de Tab IP 180 mg

[Fexodil- 180]

T 3105

10/24

09/26

Jackson Laboratories Pvt Ltd, 22-24, Majitha Road, Byepass, Amritsar -143 001

It fails the test ‘Dissolution’ as per IP

Drugs Testing Laboratory Thiruvananthapuram

90.

Glimepiride Tablet IP 1 mg

D2505/24

-25

Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14

It fails the test dissolution and ‘Descriptive Part’ specified in the Laboratory Protocol as

per IP

Drugs Testing Laboratory Thiruvananthapuram

91.

Vitamin B Complex Tablets NFI

S0016/24

-25

Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14

The sample does not conform to IP standards with respect to ‘Descriptive Part’ for tablets.

Drugs Testing Laboratory Thiruvananthapuram

92.

Glimepiride Tablet IP 1 mg

D2721/24

-25

Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14

The sample does not conform to IP standards with respect to ‘Descriptive Part’ for

tablets.

Drugs Testing Laboratory Thiruvananthapuram

93.

Glimepiride Tablet IP

D2854/24

-25

Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14

The sample does not conform to IP standards with respect to ‘Descriptive Part’ for tablets.

Drugs Testing Laboratory Thiruvananthapuram
Also Read:Drug Alert: CDSCO Flags 51 Formulations As Not Of Standard Quality
To view the official notice, click the link below:
https://medicaldialogues.in/pdf_upload/state-nsq-alert-for-the-month-of-january-2025-276688.pdf

Powered by WPeMatico

Woman doctor found dead under mysterious circumstances

In an unfortunate incident, a clinical associate of Ladies Clinic and Nursing Home, Cuttack, allegedly committed suicide by hanging herself from the ceiling at her residence in Daraghabazar in Cuttack, Odisha.

A preliminary report from the police investigation indicates that the doctor identified as Dr Alaka Rath was suffering from mental distress for a considerable time. Therefore, it is suspected that this may have led her to take her own life. However, the police have yet to confirm the cause behind this tragic incident.

For more information, click on the link below:

Powered by WPeMatico

CAG report exposes critical gaps in Delhi’s healthcare system

The audit report on the Delhi Government‘s “Public Health Infrastructure and Management of Health Services”, prepared by the Comptroller and Auditor General (CAG) of India, revealed shocking gaps in Delhi’s healthcare facilities.

This being the second CAG report, has reviewed the status of government hospitals, mohalla clinics, and other health facilities of the Delhi Government. The availability of machines in government hospitals, supply of medicines, number of doctors and nurses, and facilities provided to the patients have also been assessed in the CAG report.

For more information, click on the link below:

Powered by WPeMatico

HC directs GMC Jalna to restore admission of PwD MBBS aspirant

Coming to the rescue of a medical aspirant suffering from multiple disabilities, who was declared ineligible for MBBS admission, the Bombay High Court has ordered the Government Medical College, Jalna to create a supernumerary seat for the candidate to ensure his admission to the MBBS course.

The HC bench comprising Justices AS Chandurkar and MM Sathaye held that based on the quantification of the petitioner’s disability vide the Certificate dated 6th August 2024, coupled with the assessment of his functional competency to pursue the medical course as opined by the Disability Board on 23rd October 2024, the petitioner was entitled to pursue medical education by seeking the benefit of PwD reservation.

For more information, click on the link below:

Powered by WPeMatico

Health Bulletin 01/ March/ 2025

Here are the top health news for the day:

Non-Registration of FIR of doctor: HC slams Delhi Police, upholds Rs 50,000 fine

The Delhi High Court recently upheld the National Human Rights Commission‘s (NHRC) order directing the Delhi Police Commissioner to pay Rs 50,000 compensation to a senior doctor for not registering an FIR regarding a complaint involving instances of violence against him.

Earlier, the NHRC on 27.09.2023 had recommended that the Commissioner release Rs 50,000 compensation to the doctor. Following this, the order was challenged by the Police Commissioner before the Delhi High Court.

For more information, click on the link below:

CAG report exposes critical gaps in Delhi’s healthcare system, highlights key deficiencies

The audit report on the Delhi Government‘s “Public Health Infrastructure and Management of Health Services”, prepared by the Comptroller and Auditor General (CAG) of India, revealed shocking gaps in Delhi’s healthcare facilities.

This being the second CAG report, has reviewed the status of government hospitals, mohalla clinics, and other health facilities of the Delhi Government. The availability of machines in government hospitals, supply of medicines, number of doctors and nurses, and facilities provided to the patients have also been assessed in the CAG report.

For more information, click on the link below:

HC directs GMC Jalna to restore admission of PwD MBBS aspirant 

Coming to the rescue of a medical aspirant suffering from multiple disabilities, who was declared ineligible for MBBS admission, the Bombay High Court has ordered the Government Medical College, Jalna to create a supernumerary seat for the candidate to ensure his admission to the MBBS course.

The HC bench comprising Justices AS Chandurkar and MM Sathaye held that based on the quantification of the petitioner’s disability vide the Certificate dated 6th August 2024, coupled with the assessment of his functional competency to pursue the medical course as opined by the Disability Board on 23rd October 2024, the petitioner was entitled to pursue medical education by seeking the benefit of PwD reservation.

For more information, click on the link below:

Woman doctor found dead under mysterious circumstances
In an unfortunate incident, a clinical associate of the Ladies Clinic and Nursing Home, Cuttack, allegedly committed suicide by hanging herself from the ceiling at her residence in Daraghabazar in Cuttack, Odisha.

A preliminary report from the police investigation indicates that the doctor identified as Dr Alaka Rath was suffering from mental distress for a considerable time. Therefore, it is suspected that this may have led her to take her own life. However, the police have yet to confirm the cause behind this tragic incident.

For more information, click on the link below:

Powered by WPeMatico

Want to Pursue DM, DrNB Clinical Immunology and Rheumatology? Check Out NEET SS feeder Qualification

New Delhi: For the NEET SS 2024 aspirants seeking admission to DM Clinical Immunology and Rheumatology, MD/DNB (General Medicine), and MD/DNB (Paediatrics) have been designated as the feeder qualification.

DM/DrNB Clinical Immunology and Rheumatology or Doctorate of National Board in Clinical Immunology and Rheumatology also known as DM/DrNB in Clinical Immunology and Rheumatology is a super specialty level course for doctors in India that is done by them after completion of their postgraduate medical degree course. The duration of this super specialty course is 3 years, and it focuses on the diagnosis and treatment of autoimmune diseases and rheumatological disorders.

The NEET SS 2024 application process has ended recently and the correction window is ongoing. As per the information bulletin released by the National Board of Examinations (NBE), the feeder qualification for DM/DrNB Clinical Immunology & Rheumatology is MD/DNB (Pathology) defined by the NBE and is subject to changes by the NBE.

The eligibility criteria for DM/DrNB Clinical Immunology & Rheumatology are defined as the set of rules or minimum prerequisites that aspirants must meet in order to be eligible for admission, which include:

Name of
Super Specialty Course		 Course Type Prior
Eligibility Requirement
Clinical Immunology & Rheumatology DM/DrNB MD/DNB
(General Medicine)
MD/DNB (Paediatrics)

NEET SS 2024:

ELIGIBILITY CRITERIA

The applicant must meet/fulfil the following criteria-

1 Candidates who have a recognized postgraduate medical Degree/Provisional Pass Certificate (MD/MS/DNB) or equivalent recognized qualification or are likely to have the same by 30th April 2025 by eligible feeder speciality qualifications for super speciality courses as mentioned in Annexure B of this Information Bulletin can apply for NEET-SS 2024.

2 Candidates found to be ineligible at any stage of NEET-SS 2024 will not be permitted to appear in the examination. In the unlikely event of any ineligible candidate appearing and/or being successful in NEET-SS 2024, the result/ candidature of such candidate shall be cancelled and/or is deemed to be cancelled as and when the ineligibility is detected.

3 The cutoff date for qualifying MD/MS/DNB Broad Specialty/ eligible feeder qualification towards determination of eligibility for appearing in NEET-SS 2024 shall be 30th April 2025.

4 Requests for appearing in NEET-SS 2024 from candidates who are qualifying and/or getting the results of their MD/MS/DNB qualifications/eligible feeder qualifications after 30th April 2025 shall be summarily rejected.

5 Registration with NMC/State Medical Council is mandatory and its documentary proof should be furnished at the test Centre on the examination day.

6 Foreign Nationals including Overseas Citizen of India (OCI) cardholders can appear in NEET-SS 2024 without registration with the National Medical Commission (NMC). The NMC may, on payment of the prescribed fee for registration, grant temporary registration for the duration of the post-doctoral course limited to the medical college/institution to which he/she is admitted for the time being exclusively for pursuing postdoctoral studies. Provided further that temporary registration to such foreign national shall be subject to the condition that such person is duly registered with appropriate registering authority in his/her own country where he has obtained his PG Medical qualification and is duly recognised by the corresponding Medical Council or concerned authority.

7 Candidates already pursuing or have joined a Doctoral Course (DM/MCh/DrNB) through NEET-SS are not eligible for admission to DrNB Superspecialty courses through NEET-SS 2024 for the entire duration prescribed for the course already joined by them earlier. This shall be irrespective of their resignation or discontinuation from the said course due to any reason.

8 The FCPS qualifications awarded by the College of Physicians and Surgeons, Mumbai are not equivalent to either MD or MS courses. Accordingly, candidates possessing FCPS qualifications awarded by the College of Physicians and Surgeons, Mumbai are not eligible to apply for NEET-SS, solely based on their FCPS qualifications.

9 Eligibility of candidates issued admit card for the examination shall be purely provisional. Appearing in NEET-SS 2024 does not confer any automatic rights upon the candidate for admission to DM/MCh/DrNB Super Specialty courses.

Examination Fee

Examination Fee per Group*

Rs. 3500

*Excluding charges as may be applicable by various payment gateways. GST has been EXEMPTED as per Department of Revenue, Ministry of Finance, Govt of India circular no 151/07/2021-GST dated 17.06.2021

Candidate shall be required to pay the examination fee as mentioned above for each group in which he/she chooses to appear. For eg. A candidate with MD Paediatrics qualification who chooses to appear in question papers for both Medical and Paediatric Groups shall be required to pay Rs. 3500 + 3500 = 7000/- towards examination fee. Please refer chapter on details of scheme of examination

Applications forms once submitted cannot be withdrawn. Fee shall neither be carried forward to a future date nor refunded under any circumstances. Application once submitted cannot be withdrawn. Any claim for refund, adjustment or carrying forward of Application fee will not be entertained.

How to pay: The prescribed exam fee should be remitted through payment gateway provided using a Credit Card or a Debit Card issued by banks in India or other modes as may be made available and have been provided on the web page. Fee can not be deposited through any mode other than the payment gateway available while submitting online application form submission.

Examination fees in respect of candidates who are absent or have been declared ineligible due to any reason will be forfeited. Candidates are advised to read the information bulletin for NEET SS 2024 carefully and pay examination fee only if they fulfil eligibility criteria prescribed in the bulletin.

Meanwhile, NBEMS will be conducting the NEET-SS 2024 in two slots in 2 days on a computer-based platform at various exam centres across the country. Interested candidates can start submitting the application form for the NEET-SS 2024. Below is the complete schedule-

SCHEDULE

S.NO

PROCESSES

TIMELINES

1

Online Application Submission.

4th February 2025 (3 PM Onwards) to 24th February 2025 (Till 11:55 PM).

2

Edit Window for All Applicants.

27th February 2025 to 3rd March 2025.

3

Final Edit Window to Rectify Deficient/Incorrect Images (No further opportunity shall be given)

1 Photograph.

2 Signatures.

3 Thumb Impression.

11th March 2025 to 13th March 2025.

4

Issue of Admit Card.

25th March 2025.

5

Examination Date.

29th & 30th March 2025.

6

Cut Off Date for qualifying MD/ MS/DNB Broad Specialty qualification towards determination of eligibility for appearing in NEET-SS 2024.

30th April 2025.

7

Declaration of Result.

By 30th April 2025.

Powered by WPeMatico

Merck to increase workforce at Indian sites by year end

Drug Maker Merck expects to boost employment in India with increment in its workforce across its India sites by the end of the year, a senior executive of the company said.

At the BioAsia conference in India’s Telangana state, Dave Williams, Executive Vice President said, “By the end of this year, we expect to have roughly 2,700 employees. And in a couple of years, I fully expect we’ll double that number or more.”

Merck’s India sites, which together employ around 1,800 people, focus on multiple therapy areas including oncology, diabetes, vaccines and animal health, as well as technology-related centers.
The U.S. drugmaker opened a new technology center in the southern Indian city of Hyderabad this week, Reuters reported.
Read also: Merck gets positive EU CHMP opinion for Pneumococcal vaccination in adults
Williams, who heads the information and digital department, said the company is looking to hire “digital innovators” who can help business partners understand the role technology can play in reducing the time taken to get new treatments to patients.

Read also: Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Powered by WPeMatico

Dehradun horror: MBBS student, wife arrested for Kidnapping, murdering 70-year-old man in Extortion Bid

Dehradun: In a shocking turn of events, a fourth-year MBBS student and his wife have been arrested for allegedly kidnapping and murdering a 70-year-old retired man in a desperate attempt to extort money for medical college fees. Facing financial constraints and fearing an inability to complete his studies, the student, along with his wife, hatched a plan to blackmail the elderly man. However, when their scheme failed, they allegedly strangled him to death. 

To destroy the evidence, the accused couple took the help of their two relatives and allegedly dismembered the elderly man’s body into several pieces, packed the remains in plastic bags and dumped it in a canal in Saharanpur’s Badgaon area. The chilling crime came to light after police found the dismembered remains of the man on February 20, two weeks after he went missing.

The accused, who had been on the run since the murder, had a bounty of Rs. 25,000 each on their heads. They were recently arrested by Dehradun Police in Amritsar after an extensive manhunt across multiple cities, including Mumbai, Jaipur, and Prayagraj.

Also read- HIMS PG medico assaulted by attendants over alleged delay in patient’s treatment, 3 arrested

According to the police, the accused medical student, pursuing MBBS from a private institute in Dehradun. However, he was unable to bear the fees of the private institution and was in fear that he may not be able to complete the course on time. On top of that, he was burdened with hefty fees. As a result, the student was in need of money to complete his education.  

At that point, his wife, who was familiar with his issues, suggested to kidnap the elderly man. It is reported that his wife in the past had an affair with the elderly man. Therefore, she was aware of his financial condition. Thinking of it as a quick and easy way to extort money, the couple allegedly kidnapped the elderly man with the intent to record an obscene video of him and later blackmail him to extort money, however, when their plan failed, the couple strangled the man to death in fear of getting exposed.

The incident dates back to February 7 when the daughter of the man filed a missing complaint at the police station regarding his father’s disappearance. She claimed that his father had left home on his bike and never returned.

Based on the complaint, the police launched an investigation and found out about the man’s relationship with the wife of the medical student. During the investigation, it was discovered that the elderly man maintained an illicit relationship with the woman for the last 12 years, and therefore they shifted their focus to her. 

The case made a breakthrough when police reviewed CCTV footage showing the elderly man visiting the woman’s house but not leaving. The suspicion grew stronger when the couple was missing as they went into hiding after the murder. 

The police had earlier arrested two men, identified as the woman’s brother and brother-in-law, after evidence confirmed their involvement in disposing of the victim’s remains in the canal. To mislead investigators, they also abandoned the deceased’s bike in a secluded plot near Dehradun ISBT, removing its number plate, reports ETV Bharat. 

Explaining the incident in more detail, a police officer told TOI, “It all started a few years ago when *** was living separately in Dehradun, away from her first husband. Their three-year-old daughter was with her. ***was in a relationship with the elderly man when she met the medical student. The two got married at a temple in May last year.”

“As the student needed money to complete his MBBS course, *** told him about her past affair with the elderly man, following which the couple hatched a plan to extort money from the teacher. The money, they decided, would fund his studies. Life would be easy after he became a doctor. As per the plan, *** invited the man to a rented accommodation and the student was ready with a camera to shoot an intimate video,” the officer said.

“Along the way, though, the man got suspicious and insisted on cutting short the rendezvous. But the couple wouldn’t let him. After a brief skirmish, the couple overpowered him and in the heat of the moment strangled the old man. Being a medical student, he knew that after a day or two, the blood would clot and there would be no bleeding if the body was chopped or cut. *** then called her brother from Saharanpur to help the student dismember the body and dispose of the parts,” said SSP Singh.

After an extensive search operation, the police finally arrested the couple. During interrogation, she confessed to the police that when the elderly man arrived at the rented room on February 2, he realised their plan and began to shout. To prevent him from exposing them, the couple tied him up and, in a panic, strangled him to death.

Currently, the couple is in jail after they were produced before the court on Friday.

Also read- MBBS student absconding for 8 months arrested for appearing as dummy candidate in 2022 RPSC exam

Powered by WPeMatico